Fibromyalgia (FM) is a syndrome that produces chronic pain affecting the skeletal muscle. It generates intense pain while touching certain body spots. In addition to the increased pain sensitivity, this disease has other symptoms such as muscle stiffness, fatigue, and unrefreshing sleep, affecting patients’ quality of life.

Dra. Viviana Pérez joins to the Minuspain team as a postdoctoral research. She will work mostly with Dr. Gonzalo Yévenes, from the Universidad of Concepción.

Recommended from
Margarita Calvo *

Director of the Millennium Nucleus for the Study of Pain, MinusPain and academic of the Department of Physiology of Pontificia Universidad Católica de Chile

The study analyzed the behavior of tumor cells and what would be the factors that cause their rapid proliferation and spread throughout the body. With this, the possibility of looking for new therapies to counteract this disease opens up.

A few weeks ago we learned the story of the doctor, an expert in bioethics, Liliana Ortiz, a former academic at the Universidad de Concepción. After dealing with aggressive breast cancer, she decided to receive palliative sedation so that her death would be painless.

The Millennium Nucleus seeks to develop neuroscientific research on pain and train specialists in the scientific and clinical area to understand the condition in a comprehensive way.

The research teams led by doctors Rodolfo Madrid and María Pertusa, belonging to the Department of Biology of the Universidad de Santiago, are part of the proposals selected this 2020 by the Millennium Scientific Initiative, a program of the National Research and Development Agency, ANID .

The Pontificia Universidad Católica de Chile, the Universidad de Concepción, the Universidad de Santiago de Chile, the Universidad Católica del Norte and the Universidad de Chile formed an unpublished scientific association to investigate neuropathic pain mechanisms and find new treatment options. Neuropathic pain generates disabling physical, mental, social and work consequences and is highly prevalent. Current medications are not very effective, so the development of research to understand the mechanisms of pain and generate new therapies is essential.

Dr. Margarita Calvo, director of the Núcleo Milenio MiNuSPain, participated in the first Webinar on «Neuropathic Oncological Pain» organized by the International Committee of Women in Neuromodulation of the Argentine Society of Neuromodulation (SANE)

One in six patients, treated with existing medications, achieves relief between 30% and 50%. A multidisciplinary team seeks to combine preclinical research with clinical research and thus reach the patient more effectively.